Wisealerts.com – Mid-Day Alert for Wednesday

Recommended Stock Newsletters
 
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder


Wisealerts Newsletter

Mid-Day Alert for Wednesday 3-14-12

 


 

 

 

 

JAZZ, an ongoing winner for our Wise Alert Members, has dipped down creating an opportunity for those who have not gotten in yet!!!!

 

JAZZ is trading at $47, a great entry point, seeing as JAZZ is known to hit up to $53 per share.

 

We recommended JAZZ at about $6 and have watched it soar to the top.. play the dips and keep an eye out for our alerts on JAZZ!

 

Keep FXCM on your screen, there seems to be a lot of attention coming into the stock!

 

FXCM shares soared +16% after the online currencies trading firm reported fourth-quarter results that topped estimates..

 

FXCM has been announcing a few headlines throughout the day check them out here: http://finance.yahoo.com/q/hs=FXCM+Headlines

 

ECTY, a biopharmaceutical company, much like a recent winner of ours VVUS, is on the rise today currently representing a +52% gain. 

 

 The Endocyte (ECYT) company shares jumped up today, after reporting quarterly losses that were not as steep as expected and saying “its EC145 and EC20 experimental drugs were granted orphan drug status in the EU”

 

 

JAZZ– Dip Opportunity

http://finance.yahoo.com/qs=JAZZ&ql=1

Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, focuses on the identification, development, and commercialization of pharmaceutical products to meet unmet medical needs.

 

FXCM-Momentum (+14.10%)

http://finance.yahoo.com/qs=FXCM&ql=0

FXCM Inc. provides online foreign exchange (FX) trading and related services to retail and institutional customers Worldwide. It provides spot FX, contracts-for-difference, spread betting, and equities and equity options trading.

 

ECYT– Percentage Gainer (+49.73%)

http://finance.yahoo.com/qs=ECYT&ql=0

Endocyte, Inc., a biopharmaceutical company, engages in developing targeted therapies for the treatment of cancer and inflammatory diseases. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs) and com

 

Make Sure to add Wise Alerts on Facebook and Twitter for constant up to date info!

 

 

The Wise Alerts Team WWW.WISEALERTS.COM

 

BE “WISE”……STAY “ALERT”…….and GOOD TRADING!!!!!!!

This report/release/advertisement is a commercial advertisement and is for general information purposes only.  We are engaged in the business of marketing and advertising companies for monetary compensation.  Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.   The disclaimer is to be read and fully understood before using our site, or joining our email list.  PLEASE NOTE WELL: Wisealerts.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.  Wisealerts.com does not provide trading, investment or tax advice, and readers shall not rely on statements by Wisealerts.com employees which purport to provide such advice.  Full disclaimer can be read at http://www.Wisealerts.com/disclaimer.htm

Release of Liability: Through use of this website viewing or using you agree to hold Wisealerts.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur.  The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Wisealerts.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Wisealerts.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.  None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Wisealerts.com.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Wisealerts.com is compliant with the Can Spam Act of 2003.  Wisealerts.com does not offer such advice or analysis, and Wisealerts.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor`s investment may be lost or impaired due to the speculative nature of the companies profiled.

All direct and third party compensation received will be disclosed within each individual email in accordance with section 17(b) of the 1 9 3 3 Securities Act. Any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies.  Wisealerts.com has not investigated the background of the third party, the hiring company. Anyone viewing our website and advertisement should assume that the hiring party and affiliates of the hiring party own shares of the profiled company of which they plan to liquidate, further understanding that the liquidation of those shares will most likely impact the share price of the profiled company negatively.  Wisealerts.com affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the share price of the security.

The Private Securities Litigation Reform Act of 1995 provides investors a `safe harbor` in regard to forward-looking statements.  Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, Wisealerts.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, Wisealerts.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Wisealerts.com is not responsible for any claims made by the companies advertised herein, nor is Wisealerts.com responsible for any other promotional firm, its program or its structure.  Wise Alerts LLC has not been compensated for JAZZ, FXCM, ECYT.

This e-mail was sent by Wise Alerts LLC, located at 409 Minnisink Road Suite A, Totowa, NJ 07512 (US). To receive no further e-mails, please click here or reply to this e-mail with “unlist” in the Subject line.

 

Related posts:

  1. Wisealerts.com – Happy New Years!!
  2. First Alert Weekly Market Review 02-12-11
  3. Wisealerts.com – Mid-Day Alert – TITL – SKTO – RNCG
  4. Wisealerts.com – Mid-Day Alert – EFGU – ISIM – RPPR
  5. Wisealerts.com – Watch List For Thursday – ONTY – DSCO – ICPA






You may also like...